Immix Biopharma (IMMX) Non-Current Assets (2020 - 2026)
Quarterly results put Non-Current Assets at $3.5 million for Q1 2026, up 13.76% from a year ago — trailing twelve months through Mar 2026 was $13.9 million (up 43.02% YoY), and the annual figure for FY2025 was $3.6 million, up 31.0%.
Immix Biopharma has reported Non-Current Assets over the past 7 years, most recently at $3.5 million for Q1 2026.
- Non-Current Assets reached $3.5 million in Q1 2026 per IMMX's latest filing, down from $3.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.6 million in Q4 2025 and bottomed at $4126.0 in Q3 2022.
- Median Non-Current Assets over the past 5 years was $1.4 million (2024), compared with a mean of $1.5 million.
- The largest annual shift saw Non-Current Assets soared 3411.05% in 2023 before it increased 13.76% in 2026.
- Over 5 years, Non-Current Assets stood at $10284.0 in 2022, then skyrocketed by 1236.15% to $137410.0 in 2023, then skyrocketed by 1901.34% to $2.8 million in 2024, then skyrocketed by 31.0% to $3.6 million in 2025, then fell by 1.7% to $3.5 million in 2026.
- Business Quant data shows Non-Current Assets for IMMX at $3.5 million in Q1 2026, $3.6 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 22.66 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 3.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.54 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 137,410.00 |
| Sep 30, 2023 | 143,271.00 |
| Jun 30, 2023 | 59,273.00 |
| Mar 31, 2023 | 178,186.00 |
| Dec 31, 2022 | 10,284.00 |
| Sep 30, 2022 | 4,126.00 |
| Jun 30, 2022 | 4,691.00 |
| Mar 31, 2022 | 5,075.00 |
| Dec 31, 2021 | 5,695.00 |
| Dec 31, 2020 | 7,361.00 |